SFT2D3 Antikörper (N-Term)
-
- Target Alle SFT2D3 Antikörper anzeigen
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SFT2D3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- SFT2 D3 antibody was raised in rabbit using the N terminal of SFT2 3 as the immunogen
- Top Product
- Discover our top product SFT2D3 Primärantikörper
-
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
SFT2D3 Blocking Peptide, catalog no. 33R-2823, is also available for use as a blocking control in assays to test for specificity of this SFT2D3 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
- Andere Bezeichnung
- SFT2D3 (SFT2D3 Produkte)
- Synonyme
- 2610206C24Rik antikoerper, AI847965 antikoerper, AW046173 antikoerper, SFT2 domain containing 3 antikoerper, SFT2D3 antikoerper, Sft2d3 antikoerper
- Hintergrund
- SFT2D3 may be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex. Synonyms: Polyclonal SFT2D3 antibody, Anti-SFT2D3 antibody, SFT2 domain containing 3 antibody, MGC5391 antibody.
-